Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center

CONCLUSIONS: Our findings along with previously published data suggest that apixaban should be considered the standard of care for VTE prophylaxis in patients undergoing open surgery for gynecologic malignancies.PMID:38368180 | DOI:10.1016/j.ygyno.2024.01.039

Source: Gynecologic Oncology - February 17, 2024 Category: Cancer & Oncology Authors: Anne Knisely Maria D Iniesta Samantha Batman Larissa A Meyer Pamela T Soliman Katherine E Cain Claire Marten Gary Chisholm Kathleen M Schmeler Jolyn S Taylor Nicole D Fleming Source Type: research